Clinical Trials Logo

Pain, Neuropathic clinical trials

View clinical trials related to Pain, Neuropathic.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04997278 Withdrawn - Clinical trials for Failed Back Surgery Syndrome

Coordinated Reset Spinal Cord Stimulation

Start date: July 12, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate whether a new spinal cord stimulation paradigm, called Coordinate Reset (CR) Stimulation, can provide equivalent or better pain relief with reduced energy requirements. The investigators will test this new stimulation paradigm in patients who are already undergoing spinal cord stimulation surgery. The investigators will also study whether there are changes in electroencephalography (brain waves) associated with this new stimulation paradigm. The investigators hope to learn whether CR stimulation can provide equivalent or better pain relief with reduced energy requirements. They also hope to learn whether there are changes in brain function with effective CR stimulation compared to conventional stimulation. This study will be testing a specific stimulation paradigm in people who have already consented to have spinal cord stimulation performed for treatment of their chronic pain.

NCT ID: NCT04466826 Withdrawn - Pain, Neuropathic Clinical Trials

Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients

Start date: January 2, 2021
Phase: Phase 2
Study type: Interventional

Single-center, open-label, pre-post treatment pilot study to evaluate the safety and effectiveness of sphenopalatine ganglia blocks for the treatment of chronic migraine in the pediatric population. 50 children with a diagnosis of chronic migraines will undergo a series of three transnasal sphenopalatine ganglia blocks to measure their effect on headache frequency, headache intensity, headache duration, and use of headache medication.

NCT ID: NCT03747562 Withdrawn - Pain, Neuropathic Clinical Trials

Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.

stREnGTH
Start date: March 1, 2019
Phase: Phase 3
Study type: Interventional

A multi-centre, double-blind, randomized-controlled trial to study the efficacy and safety of gabapentin to reduce the need for strong opioid use in the treatment of radiation-induced pain in head and neck cancer (HNCA) patients undergoing a curative 7-week radio(chemo)therapy course with curative intent. The aim of this study is to establish if addition of gabapentin is more effective in reducing the need to start (or dosage-increase) a strong opioid for HNCA pain than a matching placebo additional to standard pain management (WHO-ladder step 2 and 3).

NCT ID: NCT03609957 Withdrawn - Analgesia Clinical Trials

Exercise and Pain in Non-Hispanic Blacks and Whites

Start date: February 2019
Phase: N/A
Study type: Interventional

Non-Hispanic Blacks tend to report higher levels of pain, experience pain more frequently, and be under-treated for pain compared to non-Hispanic Whites. Acute (single session) exercise is known to be effective at reducing pain but it is unknown what effect chronic exercise training has on pain responses. The broad goal of this study is to determine whether regular exercise training is more effective at reducing pain responses in non-Hispanic Blacks compared to non-Hispanic Whites. The investigators are interested in comparing regular aerobic exercise training versus high-intensity interval training.